Content

pfeil Home

pfeil Supplemental Table 1
pfeil Supplemental Table 2
pfeil Supplemental Table 3
pfeil Supplemental Table 4
pfeil Supplemental Information ISIS splits

Max Planck Institute for Molecular Genetics Max Planck Institute for Molecular Genetics
DKH Deutsche Krebshilfe

Jaeger et al.
Gene expression signatures in melanoma tissues

No.

of sample

Tumor no.

in text

Melanoma subtype

Vertical

tumor thickness (mm)

of whole tumor

Vertical

tumor thickness (mm)

of biopsy

Clark level

Clinical stage*)

 

1.

NM1

NMM

2.90

 

2.55

L IV

IIA

2.

NM2

NMM

11.00

 

9.30

LV

IIC

3.

NM3

NMM

4.20

4.10

LIV

IIB

4.

NM4

NMM

6.00

5.73

LIV

IIB

5.

NM5

NMM

4.80

4.77

LIV

IIB

6.

SSM1

SSM

0.45

0.42

LII

IA

 

7.

SSM2

SSM

0.38

 

0.35

LIII

IA

8.

SSM3

SSM

0.80

 

0.72

LIII

IA

9.

SSM4

SSM

0.93

 

0.75

LIII

IA

10.

SSM5

SSM

0.77

0.72

LIII

IA

 

11.

SSM6

SSM

5.67

 

5.40

LV

IIB

12.

SSM7

SSM

 

0.60

 

0.60

LIII

IA

13.

SSM8

SSM

in situ

in situ

Ø

0

 

14.

 

SSM9

SSM

0.95

 

0.90

LIV

IA

14.

SSM10

SSM

1.50

 

1.50

LIII

IB

16.

SSM11

SSM

0.88

 

0.85

LIII

IA

17.

SSM12

SSM

0.41

 

0.41

LIII

IA

18.

SSM13

SSM

5.40

 

5.10

LIV

IIB

19.

ALM1

ALM

2.50

 

2.32

LIV

IIA

 

Supplementary Table 1 List of melanoma samples from primary melanomas analysed in the presented study. Nineteen tissue biopsies of different melanoma subtypes from 19 different patients were used for laser-capture micodissection of melanoma cells and DNA microarray analyses. Vertical tumor thicknesses of whole tumors reached from 0.38-11.00 mm, including one in situ melanoma. Vertical tumor thicknesses of biospies reached from 0.35-9.30 mm, including one in situ melanoma. *) Classification of clinical stage was done according to Balch CM, Buzaid AC, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Houghton Jr. A, Kirkwood JM, Mihm MF, Morton DL, Reintgen D, Ross MI, Sober A, Soong SJ, Thompson JA, Thompson JF, Gershenwald JE, McMasters KM. 2000. A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer 88:1484-1491

Last modified on October 05, 2006 by Jochen Jäger